CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Getting More Value from Logistics Quality

Optimising Logistics Quality Management for Efficient Compliance, Competitive Advantage and Customer Value

With its raison d’etre of saving lives and improving the health of people around the world, the assurance of quality lies at the very heart of the pharmaceutical production and distribution process. Cost Of Quality (COQ) is a measure of all the costs relating to the quality of a product and its adherence to regulatory and in-house standards, guidelines and expectations. Alan Kennedy at Poseidon and Courtney Soulsby at BSI British Standards Institution, explain that “Any cost that would not be incurred if the quality were perfect” is a simple way of describing COQ.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026